Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytesQi Peng, Jiaming Fan, Hao Wang et al.|Aging|2019Cited by 38
Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancerYing Zhu, Jinhai Tang|Oncology Letters|2014Cited by 19